He new formulation IDegAsp has been compared with two other unique
He new formulation IDegAsp has been compared with two other different insulin analogs IGlar or biphasic IAsp.74,75 The first 16week, openlabel, treattotarget trial has compared IDegAsp with IGlar in diabetic…